#viral_suppression — Friday, May 29, 2026 (1 items)
| 0 | 💬 0 |
Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA.
(academic.oup.com)
|
Journal of Infectious Diseases 2026-05-29 | #amr #clinical trial #hiv #viral_suppression |